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Abstract 
Moderate to severe chronic pain is a problem for 1.7 million children, costing $19.5 billion annually in the United 
States alone. Risk-stratified care is known to improve outcomes in adults with chronic pain.  However, no tool 
exists to stratify youth who present with pain complaints to appropriate interventions.  The Pediatric Pain 
Screening Tool (PPST) presented here assesses prognostic factors associated with adverse outcomes among 
youth and defines risk groups to inform efficient treatment decision-making. Youth (n=321, ages 8-18, 90.0% 
Caucasian, 74.8% female) presenting for multidisciplinary pain clinic evaluation at a tertiary care center 
participated. Of these, 195 (61.1%) participated at 4-month follow-up. Participants completed the 9-item PPST in 
addition to measures of functional disability, pain catastrophizing, fear of pain, anxiety, and depressive 
symptoms. Sensitivity and specificity for the PPST ranged from adequate to excellent, with regard to significant 
disability (78%, 68%) and high emotional distress (81%, 63%). Participants were classified into low (11%), 
medium (32%), and high (57%) risk groups. Risk groups did not significantly differ by pain diagnosis, location, or 
duration. Only 2-7% of patients who met reference standard case status for disability and emotional distress at 
4-month follow-up were classified as low-risk at baseline, whereas 71-79% of patients who met reference 
standard case status at follow-up were classified as high risk at baseline. A 9-item screening tool identifying 
factors associated with adverse outcomes among youth who present with pain complaints appears valid and 
provides risk stratification that can potentially guide effective pain treatment recommendations in the clinic 
setting.  
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There is now strong evidence that interventions such as cognitive behavioral therapy are an 
integral component of pain management for many patients[6,8]. However, access to care and 
engagement in services is hampered by factors such as a lack of available providers, scheduling conflicts, 
financial/insurance constraints, and insufficient knowledge of treatment efficacy[5,27].  Having a brief, 
validated tool to screen patients quickly for their risk of persistent symptoms and disability.  It 
alsoallows providers to match treatment options more efficiently to patient presentation and more 
effectively address their needs, given that effect sizes for general cognitive behavioral treatments for 
pediatric chronic pain are modest[6]. 
In the clinical management of adults with low back pain, one approach to stratifying patients for 
targeted treatment is through use of the Keele STarT Back Screening Tool (SBST)[13]. SBST was designed 
to identify a patient’s risk status (high, medium, or low) of poor clinical outcome using established 
biopsychosocial prognostic factors[12].  Allocation to the high-risk, more complex subgroup is primarily 
driven by the tool’s psychosocial variables, highlighting the importance of psychological factors as 
prognostic indicators of clinical outcome[4,16,26]. Using a stratified care treatment approach based on 
the SBST[13] treatments can match the increasingly complex needs of patients.  This approach is 
associated with incremental increases in quality of life years and reductions in healthcare costs related 
to back pain treatment compared to current best practice[14].  It also results in significant 
improvements indisability, particularly for high-risk patients [7]. Dissemination of the SBST has 
progressed rapidly and the tool is currently validated in several languages[2,10,20,22]. Related research 
has also found this measure to be predictive of treatment response[35] and disability outcomes six 
months after assessment[1] in adult patients with low back pain.  
Although additional prognostic models and indicators have been identified in adult pain[21], no 
similar screening measures have been developed for youth with pain complaints. In the current 
investigation, we modified the musculoskeletal version of the SBST for pediatric patients and have 
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termed this the Pediatric Pain Screening Tool (PPST). The primary aims of the PPST are to 1) rapidly 
identify addressable treatment targets (e.g., sleep disruption, pain-related fear) and 2) derive cut-off 
scores for grouping patients into low risk (few negative prognostic indicators, responsive to analgesia, 
advice, and education), medium risk (moderately unfavorable prognosis, high level of 
physical/functional prognostic indicators, appropriate for physiotherapy), and high risk (very 
unfavorable prognosis, high levels of psychosocial prognostic indicators, appropriate for physical and 
cognitive-behavioral therapy) categories.  
We hypothesized that items from the PPST would have adequate variability and test-retest 
reliability. Additionally we hypothesized that the PPST total score and psychosocial subscale would 
demonstrate acceptable discrimination of reference standard cases and non-cases (e.g., depressed vs. 
non-depressed) and we would be able to derive cutoff scores for subgrouping patients into one of three 
a priori risk groups (i.e., low, medium, high). Lastly, we hypothesized that patients who were classified as 
high risk at baseline would have the worst outcomes at 4-month follow-up, where as patients classified 
as low risk would have the most positive outcomes.   
 
Methods 
Participants and procedure 
Patients aged 8 to 18 and an accompanying parent who presented for a multidisciplinary pain 
clinic evaluation at the Chronic Pain Clinic at Boston Children’s Hospital (BCH), Boston, USA  (January 
2012 to April 2014) were invited to participate.  Patients and their parents were brought to a private 
room by a research assistant to obtain written informed consent/assent both to complete study-specific 
measures and to allow information from the clinical assessment to be used for research purposes. The 
PPST was completed specifically for this study, whereas all other measures are part of a standard clinic 
battery completed prior to their appointment on either paper (mailed to the family) or electronically (via 
A
CE
PT
ED
  Copyright  2015 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
5 
a link sent through email) at home. All participants were invited to participate in a 2-week and 4-month 
follow-up assessment via electronic data collection using REDCap software[11]. At the 2-week follow-up 
the PPST was administered exclusively the PPST while at the 4-month follow-up several additional 
measures were used to assess current functioning. The study was approved by the Institutional Review 
Board at BCH. 
Chronic Pain Clinic Multidisciplinary Evaluation and Treatment 
All patients participated in a multidisciplinary pain clinic evaluation, where the patient and 
parent(s) jointly met with a 1) physician and physical therapist and 2) clinical psychologist for two 
separate one-hour sessions. After these sessions, the treatment team met to review their assessments 
and recommendations for treatment. Following this meeting, the physician and clinical psychologist met 
together with each family to review all findings and provide recommendations. During this feedback 
session, each family received a completed Treatment Recommendation Form that outlined 
recommendations from medical, physical, and psychological disciplines. This specific form was designed 
to ensure the clarity of communicating recommended treatments from the treatment team and has 
become a standard of care in our service.  
Chronic Pain Clinic outpatient treatment typically encompasses some combination of medical, 
physical, and psychological therapy. Within this sample for medical treatment, 69% were recommended 
a new medication or dosage change to the current medication. For physical therapy, 51% were 
recommended to initiate physical therapy and 28% were recommended to continue physical therapy. 
For psychology, 68% were recommended to initiate outpatient psychological treatment and 32% were 
recommended to continue with their current provider. Adherence to treatment recommendations 
across disciplines is described in the results.  
 
Screening Tool  
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Pediatric Pain Screening Tool (PPST). This is a self-report pediatric adaptation of the 9-item STarT 
Musculoskeletal Screening Tool (SMST) that was based on the SBST (see [12] for a detailed description 
of the development of this tool).  Consistent with the SBST, the PPST consists of two subscales: Physical 
and Psychosocial. For all items, patients are instructed, “Thinking about the last 2 weeks check your 
response to the following statements.” Items 1-8 respondents check “yes” or “no.” All “yes” responses 
are scored as 1. For item 9, patients check boxes with ratings from “not at all” to “a whole lot.” The 
ratings “a lot” and “a whole lot” are scored as 1, whereas the lower ratings of “not at all”, “a little”, and 
“some” are scored as 0. Summing all items, PPST total scores range from 0 to 9. Psychosocial subscale 
scores range from 0 to 5 and 0 to 4 for the Physical subscale. The scoring format is identical to the adult 
screening tool to allow for rapid scoring and risk stratification in a busy clinical setting.  
In consultation with the creator of the SBST (JH) and experts in pain treatment (RC, DL, NS, LS) 
seven of the items were reworded to be more appropriate for a pediatric sample, whereas two items 
from the physical subscale were replaced (getting dressed slowly, pain in the upper extremity) with 
difficulties attending school[19] and sleep[31]. Getting dressed slowly was considered less germane to 
pediatric pain and upper extremity pain too specific. The PPST physical subscale consists of four items 
assessing: 1) comorbid pain, 2)  ambulating, 3) attending school and 4) sleep. The psychosocial subscale 
consists of five items assessing: 1) pain catastrophizing, 2) pain-related fear, 3) general anxiety, 4) 
depression, and 5) pain bothersomeness (see Table 1 for specific items). We retained a 9-item format 
for the PPST to ensure that it remained brief, was consistent in scoring with the adult screening tool, and 
most importantly, the included items covered the salient domains. 
 
Additional Measures 
Pain intensity. Children were asked during the psychology interview to provide their average 
pain rating on a standard 11-point numeric rating scale[32] from 0 (no pain) to 10 (most pain possible).   
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Functional disability. The Functional Disability Inventory (FDI)[34] is a 15-item scale that assesses 
difficulty in physical and psychosocial functioning due to physical health. Higher total scores indicate 
greater disability. Scores of 13-29 reflect moderate disability and scores ≥ 30 reflect severe 
disability[15]. The internal consistency in this sample was .90.   
Child fear of pain. The Fear of Pain Questionnaire for children [28] is a 24-item self-report 
inventory assessing pain-related fears. Total scores of 51 and higher are classified as high pain-related 
fear[28]. Internal consistency for the FOPQ was .91. 
Pain catastrophizing. The Pain Catastrophizing Scale, Child report (PCS-C[3]) includes 13 items 
and assesses negative thinking associated with pain. The clinical reference point for high catastrophizing 
is 26 and greater[24]. Internal reliability for the current sample was .93 for the PCS-C. 
Depressive Symptoms. The Children’s Depression Inventory (CDI-2[18]) is a 28 item self-report 
measure assessing child depressive symptoms. T-scores of 65 or greater are defined as clinically 
significant[18]. Internal reliability for the current sample was .88. 
General Anxiety. The Revised Children’s Manifest Anxiety Scale[25] is a 45-item self-report 
measure assessing anxiety symptoms. All items (excluding the lie scale) are summed to obtain a total 
anxiety score. T-scores of 60 or greater are defined as clinically significant. Internal reliability for the 
current sample was .93. 
Treatment Adherence. At 4-month follow-up assessment, parents were asked about each 
recommendation given at the CPC evaluation to treat their child’s pain in the domains of medicine, 
physical therapy, and psychology and whether they completed the recommendation (answered 
dichotomously; ‘yes’/’no’). Data were extracted on medication changes (increase/decrease dosage or 
add a new medication), physical therapy treatment (begin new treatment or continue current 
outpatient intervention), and psychology treatment (begin new psychological intervention or continue 
current outpatient intervention). The questions were modeled after the treatment recommendation 
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form that all patients receive at the end of the clinic evaluation[27,29]. 
Statistical Analyses  
Data were entered and analyzed using SPSS version 21.0 (SPSS IBM, New York, USA).  
Scale variability and repeatability. Floor and ceiling effects were considered present if > 15% of 
respondents achieved the highest/lowest possible tool scores. To investigate test-retest reliability, 2-
weeks after evaluation a subset of patients received and completed the PPST (n=221). We examined 
intra-class correlation coefficients (ICC) using a two-way random effects ANOVA model (participant x 
time-point). Given the dichotomous (yes/no) response format, we employed measures of absolute 
agreement, wherein systematic differences between time-points are considered relevant. ICC values  ≥ 
0.70 reflect adequate test-retest reliability.  To examine scale variability by pain diagnosis and location, 
one-way ANOVAs were conducted. Pearson Product Moment correlations were conducted to examine 
the association between PPST scores and duration of pain.  
Discriminant validity. Using receiver operating characteristic (ROC) curves and by calculating the 
area under the curve (AUC) for the overall PPST score and the psychosocial subscale, we compared 
scores against ‘cases’ on relevant reference standards. Reference standard multi-item measures were 
dichotomized to provide ‘cases’ and ‘non-cases’ using established cut-offs. We examined scores in 
relation to functional disability for baseline and 4-month follow-up (cases defined as FDI score of ≥ 
13[15]). For the psychosocial measures, reference standard cases were as follows: FOPQ ≥ 51[28], PCS-C 
≥ 26[24], CDI-2 T-score ≥ 65[18], RCMAS-2 T-score ≥ 60[25]. Psychosocial distress cases were identified 
for patients who were elevated on >= 2 psychosocial measures. Strength of discrimination was classified 
according to the following descriptors: 0.7- <0.8 acceptable discrimination, 0.8- <0.9 excellent 
discrimination [36].  
Deriving PPST cut-off scores. The primary goal of creating the PPST was to provide clinically 
meaningful subgroups to inform treatment decision-making. To define risk groups, we examined ROC 
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curves for PPST total and psychosocial subscale scores against reference standard cases of disability and 
psychosocial distress. As a screening tool, sensitivity was weighed as more important than specificity.  
Predictive validity. We examined the predictive ability of PPST risk groups defined at baseline on 
disability, fear, catastrophizing, depression, and anxiety outcomes at 4-month follow-up. We used chi-
square and one-way ANOVAs to examine differences across the groups based on frequency of reference 
standard cases and continuous scores at 4-month follow-up.  
Treatment by risk group. We examined treatment recommendations given by risk group using 
chi-square analysis and adherence at 4-month follow-up by baseline risk group using one-way ANOVAs.  
Treatment response. To examine treatment response, we calculated change scores for the total 
PPST scale score and each outcome of interest between baseline and 4-month follow-up: disability, fear, 
catastrophizing, depression, and anxiety. We then conducted Pearson Product Moment bivariate 
correlations between PPST change scores and each outcome. We also calculated minimal clinically 
important difference (MCID) scores for the PPST and FDI using the half standard deviation approach[23]. 
For the FDI, MCID was 6 (SD=11.4 in large cross-validation study of FDI with 1300 youth [15]). We used 
chi-square analyses to examine the frequency of patients who reported MCIDs for the PPST and FDI as 
an additional indicator of treatment response.  
 
Results 
Participants 
Of the 452 patients eligible for the study, 321 enrolled (71% recruitment rate). The primary 
reason for not enrolling was research recruitment conflicting with clinic schedule (e.g., patient arrived 
late, evaluation lengthy). Patients self-identified  predominantly as Caucasian (90%) and female (74.8%). 
Mean age was 13.73 (SD=2.47). Primary pain diagnosis included: musculoskeletal pain (43.2%), complex 
regional pain syndrome (CRPS; 18.6%), neuropathic (not CRPS; 7.3%), functional abdominal pain (6.6%), 
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headache (including chronic daily, tension, migraine, and combined headaches; 6.0%), endometriosis 
(3.5%), and other diagnoses (juvenile rheumatoid arthritis, inflammatory bowel disease, Ehlers-Danlos 
Syndrome/joint hypermobility, gynecological pain, genitourinary pain, postural orthostatic tachycardic 
syndrome, conversion disorder; 14.8%). The primary pain locations included: lower extremity (37.1%), 
upper extremity (11.3%), back/neck (19.2%), abdomen (including flank and chest, 14.2%), head 
(including jaw and face, 8.5%), hip/pelvis (5.7%), and diffuse body pain (4.1%). The duration of pain 
ranged from less than one month to over 15 years with a median duration of 13 months and 8.8% 
reported pain duration of less than 3 months. The parents were predominantly mothers (92%) and the 
majority of the parents were married (67%). The parents were generally well-educated; 64% of mothers 
completed college (42%) or a graduate degree (22%) and 60% of fathers completed college (34%) or a 
graduate degree (27%).  
For 4-month follow-up, 61% of enrolled patients participated.  There were no significant 
differences for PPST scores, functional disability, pain catastrophizing, fear of pain, general anxiety, and 
depression at the time of evaluation between the group of individuals who completed 4-month follow-
up measures (n=195) and those who did not complete 4-month follow-up measures (n=126).  The 
relative frequency of recommendations did not significantly differ for medical, physical therapy, or 
psychological treatments between those who completed follow-up and those who did not.  
Scale variability and repeatability. Among the nine items on the PPST, “pain being problematic” 
(79.2%) was the most frequently endorsed item, whereas “worry about the pain not getting better” 
(36.6%) was least frequently endorsed. Frequency of endorsement for each item is detailed in Table 1. 
With regards to total scores on the PPST, 2.2% of respondents scored 0 and 5.3% scored 9, thus there 
was no evidence of floor/ceiling effects. Using one-way ANOVAs PPST total scores did not significantly 
differ by pain diagnosis, f(6, 310)=1.09, ns, or pain location,  f(6, 311)=1.15, ns, and scores were not 
associated with pain duration based on bivariate correlation analyses (r=-0.02, ns). The total PPST score 
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(ICC = 0.75) and psychosocial subscale (ICC = 0.70) demonstrated acceptable 2-week test-retest 
reliability.  
Discriminant validity. We generated receiver operating characteristic curves to derive the area 
under the curve (AUC) for the overall PPST score and psychosocial subscale against reference standard 
cases to examine how well the screening tool could discriminate cases from non-cases. The area under 
the curve (AUC) for the overall PPST score ranged from .68 (for pain catastrophizing) to 0.80 (functional 
disability), reflecting adequate to excellent discrimination (Table 2). For the PPST psychosocial subscale, 
the AUC was adequate to acceptable (0.68-0.76).  
Deriving PPST cutoff scores. Based on the approach used for the SBST[13] we examined ROC 
curves to derive cutoff scores for the PPST. The ROC curves for disability and psychosocial distress are 
depicted in Figure 1. A PPST total score of 5 or greater was the best concurrent predictor of a reference 
standard case of moderate to severe functional disability. For the PPST psychosocial subscale, a score of 
3 or greater was the best concurrent predictor of a reference standard psychosocial distress case. Given 
these two cut-off scores, the low-risk group was defined as a PPST total score of 0-2 (PPST total cutoff 
for disability minus the PPST psychosocial subscale cutoff for psychosocial distress). For the high-risk 
group, given that it is driven by psychosocial factors, a score of 3 or greater for the PPST psychosocial 
subscale was defined as high-risk and lastly, a total PPST score ≥ 3 and psychosocial subscale 0-2 was 
defined as medium risk (see Figure 2 for scoring rubric). Within this tertiary care sample, 11% were 
classified as low risk, 32% as medium risk, and 57% as high risk. Importantly, PPST risk group did not 
significantly differ by pain diagnosis, pain location, or duration of pain.  
Predictive validity by risk group. Table 3 details the frequency of cases at follow-up by baseline 
risk group. Among patients at the 4-month follow-up, a very small percentage (2-7%) of reference 
standard case status at 4-month follow-up (e.g., clinically significant depression at 4-month follow-up) 
were classified as low-risk at baseline  At  follow-up a very high percentage (71-79%) of patients who 
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met reference standard case status for disability, catastrophizing, fear, anxiety, and depression at 
follow-up were classified as high risk at baseline (Table 3). With regards to continuous outcome values, 
the omnibus ANOVAs were significant for each outcome (see Table 4). Specifically, the baseline low risk 
group had significantly lower disability at follow-up compared to the two other risk groups, while the 
baseline high-risk group had significantly higher pain catastrophizing, fear of pain, anxiety, and 
depressive symptoms compared to the other two risk groups.  
Treatment by risk group. There was no significant difference by PPST risk group status on 
whether or not patients received treatment recommendations for medication changes, physical 
therapy, or psychological treatment. We examined adherence to treatment recommendations by 
baseline risk status. Overall patients were quite adherent to medical medication recommendations 
(94%) and physical therapy recommendations (92%), while relatively less adherent to psychology 
treatment recommendations (73%). Patients who were classified as high risk at baseline were 
significantly less likely to be adherent to psychology treatment recommendations (35%) compared to 
low risk (17%) and medium risk (18%) patients, Χ2(2)=6.69, p<0.05. No differences by risk status 
emerged for medical or physical therapy treatment adherence.  
Treatment response. We examined the association between changes in PPST scores from 
evaluation to 4-month follow-up and changes in disability, catastrophizing, fear, anxiety, and depression 
from evaluation to 4-month follow-up. We observed robust associations between decreases in PPST 
scores at 4-month follow-up and decreases in functional disability (r=0.70, p<0.01), pain catastrophizing 
(r=0.52, p<0.01), pain-related fear (r=0.46, p<0.01), and depression (r=0.46, p<0.01), with moderate 
effects for changes in general anxiety (r=0.29, p<0.01).  
The PPST at baseline had a mean of 5.31 and standard deviation of 2.17, thus a minimal clinically 
important difference (MCID) was defined as a 1-point decrease on thismeasure. Among the patients 
who reported a MCID on the functional disability inventory (6-point or greater decrease at 4-month 
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follow-up) 85% also reported a MCID on the PPST and conversely, 69% of patients who reported a MCID 
on the PPST reported a MCID on the FDI, Χ2(2)=54.2, p<0.01. 
 
Discussion 
This study introduces a valid screening tool to identify prognostic factors associated with 
adverse outcomes among youth who present with pain complaints and defines risk groups that can 
efficiently inform treatment decision-making .  The treatment of chronic pain is a challenge. Early 
identification of patients who present with impairing pain-related comorbidities (e.g., sleep disruption, 
depressed mood) has the potential to significantly improve the rate of recovery.  
 
Validity of PPST 
A key objective for this studywas to derive PPST cutoff scores for grouping patients into risk 
groups. Such groups would aid clinician decision-making for providing conservative treatment through 
education and advice (low risk), referrals for physiotherapy (medium risk), or additional referrals for 
psychological evaluation/support (high risk). Using receiver operating curves and examining the area 
under the curve, the 9-item PPST was able to discriminate reference standard cases of disability, pain 
catastrophizing, fear of pain, anxiety, and depressive symptoms. Most importantly, baseline risk groups 
robustly predicted outcomes four months later.   A very small percentage (2-7%) of patients who met 
reference standard case status (e.g., clinically elevated anxiety) at 4-month follow-up were classified as 
low risk at baseline, whereas an overwhelming percentage (71-79%) of patients who met reference 
standard case status for disability, catastrophizing, fear, anxiety, and depression at follow-up were 
classified as high risk at baseline. These results provide strong support for the utility of PPST in the clinic 
setting.   
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It is currently estimated that moderate to severe chronic pain is a problem for 1.7 million 
children costing 19.5 billion dollars per year.  That places pediatric chronic pain on par with the most 
expensive pediatric health conditions, namely ADHD and asthma[9]. Unfortunately, it is often very 
difficult for providers to know what interventions are necessary for treatment.  One research study 
found that pediatricians could not agree on the cause of a chronic pain presentation in 57% of patients.  
Moreover physicians could not agree on a diagnostic approach to treating the symptoms for over one-
third of these patients[17].  This lack of consensus conveys how challenging it is to decipher the various 
clinical and psychological correlates of chronic pain, and highlights exactly how hard it can be to know 
exactly how to treat the pain problem.  With emerging research now documenting that untreated or 
persistent chronic pain in childhood can predispose the development of adult chronic pain[33], effective 
screening tools such as the PPST are needed to more effectively identify necessary treatments.  
 
Use of PPST 
Providing targeted treatment early is of upmost importance for optimal clinical care. The current 
investigation puts forth a brief and clinically meaningful tool to screen patients who present with pain 
complaints. The PPST identifies modifiable targets for primary (e.g., sleep hygiene), secondary (e.g., 
addressing anxiety/depression), and tertiary care interventions (e.g., interdisciplinary treatment with 
psychology and PT for elevated pain-related fear). This measure may fill a currently unmet need for 
providers (e.g., pediatricians, gastroenterologists, orthopedists, neurologists) who see pediatric patients 
with pain in their practice, as it represents the first screening tool in pediatric pain and is quick to 
complete and score (1-2 minutes). Once administered, the cutoff scores clearly identifying a patient’s 
level of risk are immediately accessible, thus allowing providers to effectively integrate this information 
into a tailored treatment plan.  PPST scores appear to be invariant by pain diagnosis and pain location, 
supporting the generalizability of this measure across pain complaints.  
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In the current study clinicians did not have access to PPST scores and we did not find any 
association between risk status and treatment recommendations given at the CPC evaluation. It will be 
important to examine in future studies if PPST risk-stratified treatment recommendations results in 
better treatment matching, higher adherence to psychological treatment recommendations, greater 
healthcare savings, and improved outcomes.  
To extend the potential clinical utility of the measure, we also examined potential treatment 
responsivity of the PPST. Decreases in PPST scores were robustly associated with improvements in 
distress and functioning. Additionally, 85% of patients who reported a minimally clinically important 
difference (MCID) in functional disability at 4-month follow-up also reported a MCID on the PPST, 
suggesting that this brief tool has the potential to measure patient progress and treatment response, 
echoing recent results in adult back pain [35]. 
 
Limitations and future directions 
The items for the PPST were thoughtfully selected based on the SMST and clinical expertise of 
the study team. However, due to the focus on maintaining a brief (9-item) tool, the PPST items may not 
include all dimensions associated with heightened risk. As a departure from the adult tool, we did 
incorporate items on sleep and school functioning, which the clinical experts on the study team believed 
to be key issues among pediatric pain patients and is reflected in the literature. This is reinforced by the 
high frequency of endorsement of these two items in our chronic pain clinic sample. Although the 
dichotomous scoring format of the PPST allows for ease of scoring in a busy clinical setting, it does 
truncate score distribution and range. The lack of ceiling and floor effects for the PPST in this sample as 
well as evidence of treatment sensitivity does temper this concern. Additionally, the PPST was validated 
in a tertiary care clinic and may operate differently in a primary care setting. For example, only 11% of 
patients in this study were classified as low risk whereas the low risk group in the adult primary care 
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study ranged from 40-47% [13]. We believe that this discrepancy accurately reflects the level of 
impairment among patients who present to a specialized chronic pain clinic and is further underscored 
by the high number of patients who were recommended for psychological treatment within this sample. 
It will be important to further validate the PPST in specialty (e.g., gastroenterology) and primary care 
settings. Although the large number of reference standard cases observed at baseline and at 4-month 
follow-up afforded us the opportunity to robustly test predictions with the PPST, the results need to be 
replicated in a less clinically complex sample.  
 This tool is poised to be the cornerstone of a stratified care trial implemented in primary and 
secondary (e.g., gastroenterology) clinics, wherein the PPST is administered and patients are either 
randomized to received current best practice or stratified cared based on PPST risk categorization (e.g., 
medium risk = referral for PT evaluation). A stratified care trial will enable us to evaluate if using this 
measure to inform treatment decisions will result in more targeted care that results in potentially less 
chronicity and health care savings. Additionally, it would likely be quite beneficial to create a screening 
tool for parent risk of poor outcomes (e.g., parent’s own distress and behaviors).  
 
Conclusions  
As we make inroads toward our understanding of how to most effectively manage persistent 
pain in youth, more attention to matching treatment to the patient is warranted [30]. The PPST allows 
providers to quickly and effectively identify the medium to high-risk youth who will benefit from access 
to more comprehensive treatments.  Targeting the more entrenched biological and psychological factors 
that may maintain chronic pain early in the diagnostic process may ultimately improve recovery rates 
and alter maladaptive long-term trajectories.  
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Figure Legends. 
Figure 1. Scoring cut-offs for subgroup allocation. Receiver operating characteristic (ROC) curves for 
overall tool score and psychosocial subscale score against reference standard cases for A) Disability 
(total), B) Psychosocial distress defined using catastrophizing, fear, depression, anxiety (psychosocial 
subscale). Boxed numbers indicate sensitivity and specificity values. The green line signifies the null. 
 
Figure 2. PPST Scoring Rubric.  
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Table 1. Frequency of PPST item endorsement.  
  
PPST items Agree Disagree 
Physical Subscale   
     My pain is in more than one body part. 69.4% 30.6% 
     I can only walk a short distance because of my pain. 56.8% 43.2% 
     It is difficult for me to be at school all day.  73.1% 26.9% 
     It is difficult for me to fall asleep and stay asleep at night. 63.6% 36.5% 
Psychosocial Subscale   
     It’s not really safe for me to be physically active.  45.9% 54.1% 
     I worry about my pain a lot. 48.3% 51.7% 
     I feel that my pain is terrible and it’s never going to get any better. 36.6% 63.4% 
     In general, I don’t have as much fun as I used to. 61.7% 38.3% 
     Overall, how much has pain been a problem in the last 2 weeks?* 79.2% 20.8% 
Note. For this item, patients respond “not at all”, “a little”, “some”, “a lot”, and “a whole lot.” Responses 
of “a lot” and “a whole lot” are in the Agree column and coded as endorsement of bothersomeness for 
the total scale.  
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 Table 2: Discriminate validity: area under the receiver operating characteristic curve (AUC) for screening 
tool overall scores and psychosocial subscale scores against reference standard cases. 
 
Reference Standards 
 
Case Definition 
 
Overall tool scores, 
AUC (95% CI) 
Psychosocial subscale 
scores, AUC (95% CI) 
Disability  FDI ≥ 13 .80 (.75-.86)  
Disability (4 months 
later) 
FDI ≥ 13 .72 (.65-.79)  
Catastrophizing PCS-C ≥ 26 .68 (.62-.74) .68 (.62-.74) 
Fear FOPQ ≥ 51 .80 (.74-.85) .76 (.71-.82) 
Depression CDI ≥ 65 .78 (.72-.84) .75 (.69-.82) 
Anxiety RCMAS                  
T-score ≥ 60 
.74 (.67-.81) .72 (.65-.80) 
Psych Index Case on 2 or 
more psych 
variables* 
.79 (.73-.84) .76 (.70-.81) 
Note. 95% CI = 95% confidence interval; *Psych variables include catastrophizing, fear, depression, 
anxiety.  
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 Table 3. Baseline risk group and disability, pain catastrophizing, fear, anxiety, and depression cases at 
follow-up. 
 
 Baseline Risk Group  
 Low Medium High Chi-square 
value 
Follow-up Functioning     
     Moderate to Severe 
Disability  
2% (n=2) 26% (n=24) 71% (n=65) 20.2** 
     High Pain Catastrophizing  6% (n=4) 16% (n=11) 78% (n=54) 17.1** 
     High Fear of Pain  4% (n=2) 18% (n=9) 78% (n=40) 11.6** 
     Clinically Anxious 7% (n=2) 14% (n=4) 79% (n=23) 5.84* 
     Clinically Depressed 2% (n=1) 20% (n=9) 78% (n=36) 6.11* 
Note. Bold values are proportions significantly different at the .05 level; *p < .05; **p < .01. 
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 Table 4. Baseline risk group and disability, pain catastrophizing, fear, and depression scores at follow-up. 
 
 Baseline Risk Group  
 Low 
M (SD) 
Medium 
M (SD) 
High 
M (SD) 
F 
Follow-up 
Functioning 
    
     Functional 
Disability  
4.22 (5.62)
a 12.8 (11.0)
b 15.9 
(11.3)
b 
11.4** 
     Pain 
Catastrophizing  
13.5 (10.9)
a 16.5 (10.5)
a 25.7 
(13.4)
b 
15.5** 
     Fear of Pain  17.1 (17.8)
a 27.8 (19.9)
a 40.5 
(22.4)
b 
14.4** 
     Anxiety 41.7 (10.1)
a 42.4 (10.7)
a 49.3 
(12.0)
b 
8.58** 
     Depression 47.2 (8.87)
a 50.9 (10.7)
a 56.1 
(11.5)
b 
8.00** 
Note. *p < .05; **p < .01. 
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